نتائج البحث

المساهمون: Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad (España), Red Española de Investigación en Patología Infecciosa, European Commission, Ministerio de Economía y Competitividad (España)

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname
Antimicrob Agents Chemother

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Klebsiella pneumoniae, 030106 microbiology, Clinical Therapeutics, Meropenem, beta-Lactamases, law.invention, 03 medical and health sciences, 0302 clinical medicine, Bacterial Proteins, law, Internal medicine, medicine, polycyclic compounds, Humans, Ventilator-associated pneumonia, Pharmacology (medical), 030212 general & internal medicine, Mortality, Retrospective Studies, Pharmacology, biology, business.industry, Hazard ratio, Pneumonia, Ventilator-Associated, Retrospective cohort study, biochemical phenomena, metabolism, and nutrition, biology.organism_classification, medicine.disease, bacterial infections and mycoses, Intensive care unit, Confidence interval, Anti-Bacterial Agents, Klebsiella Infections, respiratory tract diseases, Pneumonia, KPC, Infectious Diseases, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3d889721eeba3ce3d8dcfd6ecf0f83fTest
http://hdl.handle.net/10261/230130Test

5

mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence

المؤلفون: M. Dolores Ayllón Terán, A. Poyato, Manuel de la Mata, Marina E. Sánchez-Frías, Víctor Amado, Marta Guerrero, Gustavo Ferrín, Ruben Ciria, J.C. Pozo, Sandra González Rubio, Manuel Rodríguez-Perálvarez, José Luis Montero, P. Barrera

المصدر: International Journal of Molecular Sciences, Vol 20, Iss 2, p 336 (2019)
International Journal of Molecular Sciences 20(2), 336 (2019)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
International Journal of Molecular Sciences
Volume 20
Issue 2

مصطلحات موضوعية: Male, Hepatocellular carcinoma, medicine.medical_treatment, Kaplan-Meier Estimate, Liver transplantation, Gastroenterology, lcsh:Chemistry, 0302 clinical medicine, Medicine, Phosphorylation, Prospective cohort study, lcsh:QH301-705.5, Spectroscopy, immunosuppression, liver transplantation, TOR Serine-Threonine Kinases, Liver Neoplasms, Immunosuppression, General Medicine, hepatocellular carcinoma, Middle Aged, Computer Science Applications, 030220 oncology & carcinogenesis, mTOR, Female, 030211 gastroenterology & hepatology, Signal Transduction, medicine.medical_specialty, Cell signaling, Carcinoma, Hepatocellular, Article, Catalysis, Inorganic Chemistry, 03 medical and health sciences, Internal medicine, Humans, Physical and Theoretical Chemistry, Molecular Biology, PI3K/AKT/mTOR pathway, Proportional Hazards Models, Cell growth, business.industry, Proportional hazards model, Organic Chemistry, medicine.disease, digestive system diseases, ROC Curve, lcsh:Biology (General), lcsh:QD1-999, Multivariate Analysis, Neoplasm Recurrence, Local, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ab0cb6d6008f2dbcafa4e53bb3e2d0Test
http://www.mdpi.com/1422-0067/20/2/336Test

6

Everolimus is safe within the first month after liver transplantation

المؤلفون: Víctor González, J.C. Pozo, A. Poyato, P. Barrera, José Luis Montero, Manuel Rodríguez-Perálvarez, Manuel de la Mata, Marina E. Sánchez-Frías, Indhira Pérez-Medrano, Gustavo Ferrín, Marta Guerrero-Misas, Javier Briceño, Ruben Ciria

المصدر: Transplant Immunology. 33:146-151

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e1941def3da694332a84e9ae5b68fafTest
https://doi.org/10.1016/j.trim.2015.09.002Test

7

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

المساهمون: [Temkin, Elizabeth] Tel Aviv Sourasky Med Ctr, Dept Epidemiol & Prevent Med, Tel Aviv, Israel, [Carmeli, Yehuda] Tel Aviv Sourasky Med Ctr, Dept Epidemiol & Prevent Med, Tel Aviv, Israel, [Beovic, Bojana] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia, [Benito, Natividad] Hosp Santa Creu & Sant Pau, Dept Med, Infect Dis Unit, Barcelona, Spain, [Benito, Natividad] Univ Autonoma Barcelona, Inst Invest Biomed St Pau, Barcelona, Spain, [Giannella, Maddalena] Univ Bologna, S Orsola Malpighi Hosp, Dept Med & Surg Sci, Infect Dis Unit, Bologna, Italy, [Gilarranz, Raul] Hosp Univ Gran Canaria Doctor Negrin, Dept Clin Microbiol, Las Palmas Gran Canaria, Spain, [Jeremiah, Cameron] St Vincents Hosp, Dept Infect Dis, Melbourne, Vic, Australia, [Loeches, Belen] Hosp Univ La Paz IdiPAZ, Infect Dis Unit, Madrid, Spain, [Mora-Rillo, Marta] Hosp Univ La Paz IdiPAZ, Infect Dis Unit, Madrid, Spain, [Ramos Ramos, Juan Carlos] Hosp Univ La Paz IdiPAZ, Infect Dis Unit, Madrid, Spain, [Torre-Cisneros, Julian] Hosp Univ Reina Sofia, Dept Infect Dis, Cordoba, Spain, [Machuca, Isabel] Hosp Univ Reina Sofia, Dept Infect Dis, Cordoba, Spain, [Torre-Cisneros, Julian] Univ Cordoba, Inst Maimonides Invest Biomed, Cordoba, Spain, [Machuca, Isabel] Univ Cordoba, Inst Maimonides Invest Biomed, Cordoba, Spain, [Jose Jimenez-Martin, Maria] Hosp Clin San Carlos, Crit Care Dept, Madrid, Spain, [Sanchez-Garcia, Miguel] Hosp Clin San Carlos, Crit Care Dept, Madrid, Spain, [Antonio Martinez, Jose] Univ Barcelona, IDIBAPS, Hosp Clin, Dept Infect Dis, Barcelona, Spain, [Navas, Enrique] Hosp Ramon & Cajal, Dept Infect Dis, Madrid, Spain, [Osthoff, Michael] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland, [Carlos Pozo, Juan] Hosp Univ Reina Sofia, Dept Crit Care Med, Cordoba, Spain, [Rodriguez, Marina] Hosp Univ Reina Sofia, Dept Crit Care Med, Cordoba, Spain, [Viale, Pierluigi] Alma Mater Studiorum Univ Bologna, Dept Med Surg Sci, Bologna, Italy, [Wolff, Michel] Ctr Hosp Univ Bichat Claude Bernard, AP HP, Paris, France, [Wolff, Michel] Univ Paris Diderot, Paris, France, [Carmeli, Yehuda] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel, AstraZeneca, Ministerio de Economia y Competitividad, Instituto de Salud Carlos III, European Development Regional Fund (ERDF)

المصدر: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

مصطلحات موضوعية: 0301 basic medicine, Male, Antibiotics, Salvage therapy, Bacteremia, medicine.disease_cause, Ceftazidime, Medical microbiology, Plus metronidazole, Pharmacology (medical), Blood-stream infections, Case report form, ceftazidime-avibactam, case series, Klebsiella-pneumoniae, Double-blind, Klebsiella oxytoca, Middle Aged, Anti-Bacterial Agents, Exact test, Drug Combinations, Klebsiella pneumoniae, Infectious Diseases, Combination, Pseudomonas aeruginosa, Female, Safety, medicine.drug, medicine.medical_specialty, Efficacy, medicine.drug_class, 030106 microbiology, carbapenem resistance, Microbial Sensitivity Tests, Clinical Therapeutics, 03 medical and health sciences, Enterobacteriaceae, Internal medicine, medicine, Humans, Colistin-resistant, Aged, Pharmacology, Salvage Therapy, business.industry, Ceftazidime/avibactam, Clinical trial, Carbapenems, business, Azabicyclo Compounds